Cargando…
Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular Carcinoma
The only currently validated treatment for advanced hepatocellular carcinoma (HCC) is sorafenib. However, sorafenib has been mainly studied in patients with HCC developed in cirrhotic liver. Chemotherapy might be more suitable for patients with HCC in non-cirrhotic liver. We report the case of a you...
Autores principales: | Gras, Pauline, Truant, Stéphanie, Boige, Valérie, Ladrat, Laure, Rougier, Philippe, Pruvot, François-René, Hebbar, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364045/ https://www.ncbi.nlm.nih.gov/pubmed/22666208 http://dx.doi.org/10.1159/000338242 |
Ejemplares similares
-
Prolonged Survival in a Patient with Neuroendocrine Tumor of the Cecum and Diffuse Peritoneal Carcinomatosis
por: de Mestier, Louis, et al.
Publicado: (2012) -
Is Palliative Laparoscopic Hyperthermic Intraperitoneal Chemotherapy Effective in Patients with Malignant Hemorrhagic Ascites?
por: de Mestier, Louis, et al.
Publicado: (2012) -
PSA Response to Lenalidomide Therapy in a Pre-Treated Patient with Metastatic Prostate Cancer Refractory to Hormones and Chemotherapy: A Case Report
por: Gasent Blesa, Joan Manel, et al.
Publicado: (2012) -
Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage III–IV Ovarian Serous Carcinoma
por: Kawaguchi, R., et al.
Publicado: (2012) -
Carcinomatous Pericarditis in 3 Breast Cancer Patients with Long-Term Survival
por: Konishi, Takanori, et al.
Publicado: (2012)